For the 11th consecutive year, Linda Huguelet, co-leader of the Chattanooga Multiple Myeloma Networking Group will join over 30,000 hematologists and healthcare professionals from around the world at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition being held virtually and live in San Diego, CA on December 9-11, 2023. Huguelet is one of 14 support group leaders selected by the International Myeloma Foundation (IMF) from over 160 support group leaders in the United States.
During the conference, Huguelet will be brought up to date on the latest research, therapies, and tools available to myeloma patients. In turn, she will be reporting the news to patients using social media tools like blogs, Twitter, and video. You can follow her on Twitter at @LindaMYELOMA and read her first blog at Linda Huguelet | The IMF at ASH 2023 (myeloma.org)
The IMF is the oldest and largest organization dedicated to improving the life and care of myeloma patients around the world. Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affects production of red cells, white cells and stem cells and can damage bone. It’s currently incurable and is being contracted by an increasing number of people and is particularly affecting more younger people.
Huguelet, a Signal Mountain resident, has been dealing with myeloma for over 13 years and has taken numerous treatments since her diagnosis. She most recent successfully completed CAR T-cell therapy which is one of the latest leading-edge therapies. Many myeloma patients, like Huguelet, are consistently on some type of therapy to keep the cancer under control. She says “Several new number therapies have been approved in 2023 and I look forward to learning more about those and many new treatments under development during the ASH conference. It’s so encouraging to a veteran patient like me to see new options on the horizon.” She will pass along the highlights of the encouraging research taking place when the Chattanooga Multiple Myeloma Networking Group meets after the first of the year. The Chattanooga Multiple Myeloma Networking Group meets the 2nd Thursday of each month. Meetings are currently being held virtually because myeloma patients have compromised immune systems and are especially vulnerable to COVID-19. Visit MyelomaChattanooga.org for more information on the group which provides information and support to patients and caregivers in the Chattanooga area.
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest foundation focusing specifically on multiple myeloma. The Foundation’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy. The IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned InfoLine, and in 2001, established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. In 2012, the IMF launched the Black Swan Research Initiative®, a groundbreaking research project aimed at curing myeloma. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter @IMFmyeloma.